Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000014272-16-000399
Filing Date
2016-04-28
Accepted
2016-04-28 11:32:42
Documents
78
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bmy-20160331x10q.htm 10-Q 1292684
2 COMPUTATION OF EARNINGS TO FIXED CHARGES exhibit12ratioofearningsto.htm EX-12 73857
3 SECTION 302 CERTIFICATION LETTER bmyex311_20160331.htm EX-31.A 11632
4 SECTION 302 CERTIFICATION LETTER bmyex312_20160331.htm EX-31.B 11845
5 SECTION 906 CERTIFICATION LETTER bmyex321_20160331.htm EX-32.A 3956
6 SECTION 906 CERTIFICATION LETTER bmyex322_20160331.htm EX-32.B 3956
  Complete submission text file 0000014272-16-000399.txt   7547599

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bmy-20160331.xml EX-101.INS 1778141
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmy-20160331.xsd EX-101.SCH 53161
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmy-20160331_cal.xml EX-101.CAL 119861
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmy-20160331_def.xml EX-101.DEF 174700
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmy-20160331_lab.xml EX-101.LAB 704595
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmy-20160331_pre.xml EX-101.PRE 369186
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-01136 | Film No.: 161598125
SIC: 2834 Pharmaceutical Preparations